The impact of mood disorders in neurological diseases: should neurologists be concerned?

被引：37

作者：

Kanner, AM ^{[1
]}

Barry, JJ

机构：

[1] Rush Med Coll, Rush Presbyterian St Lukes Med Ctr, Rush Epilepsy Ctr, Dept Neurol Sci, Chicago, IL 60612 USA

[2] Stanford Univ, Stanford Univ Hosp, Sch Med, Dept Psychiat, Palo Alto, CA USA

来源：

EPILEPSY & BEHAVIOR | 2003年 / 4卷

关键词：

epilepsy; stroke; poststroke depression; Parkinson's disease; multiple sclerosis; interictal dysphoric disorder of epilepsy;

D O I：

10.1016/j.yebeh.2003.08.018

中图分类号：

B84 [心理学]; C [社会科学总论]; Q98 [人类学];

学科分类号：

03 ; 0303 ; 030303 ; 04 ; 0402 ;

摘要：

Depression is one of the most frequent comorbid psychiatric disorders identified in patients with neurological disorders. The prevalence rates range between 20 and 50% of patients with stroke, epilepsy, multiple sclerosis, and Parkinson's disease. Despite these relatively high prevalence rates, depression remains underrecognized and undertreated in these patients. And yet, depression accounts for poor quality-of-life ratings and has a negative impact on the recovery from neurological symptoms. In this article, we review the epidemiological and clinical characteristics of mood disorders in patients with multiple sclerosis, Parkinson's disease, stroke, and epilepsy, and focus on the impact mood disorders have on the quality of life of these patients and on their recovery from their neurological deficits. (C) 2003 Elsevier Inc. All rights reserved.

引用

页码：S3 / S13

页数：11

共 118 条

[1] SYMPTOMATIC EFFECT OF SELEGILINE IN DE-NOVO PARKINSONIAN-PATIENTS [J].